Innovative Immunodiagnostic Platform Unveils Highly Sensitive Cancer Early-Detection Test with Predictive Treatment Insights

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Proteotype-Breakthru

More Like This

PR Newswire associated0

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

PR Newswire associated0

Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology

PR Newswire associated0

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study

PR Newswire associated0

Proteotype Launches €3 Million European Study to Advance Multi-Cancer Detection and Evaluate Home Blood Collection

Immunovia successfully completes discovery phase of next-generation test development

PR Newswire associated0

Sengenics Corporation Unveils i-Ome® Cancer: A Breakthrough in Cancer Precision Medicine

PR Newswire associated0

Kinomica Announces Multiple Abstracts on its KScan® Precision Oncology Diagnostic Platform to be Presented at the 72nd Annual Meeting of the American Society for Mass Spectrometry